| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2025-06-12 | 2025-07-04 | 260150 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-09-04 | 2018-07-31 | 20882 |
| APO-NAPROXEN SR TABLETS 750MG | 750MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-08-13 | 2017-10-05 | 19015 |
| MYLAN-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-07 | 2018-07-11 | 5916 |
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-12-21 | 2018-07-11 | 34097 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-10-19 | 2023-01-10 | 172186 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2025-07-16 | 2025-07-29 | 262910 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2025-06-17 | 2025-07-16 | 260497 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2025-04-15 | 2025-04-23 | 255076 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2025-02-19 | 2025-04-15 | 250703 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-NAPROXEN | 500MG | SUPPOSITORY | Discontinued | 2020-06-15 | 2021-10-27 | 117745 |
| PMS-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2020-06-15 | 2021-10-27 | 117865 |
| PRO-NAPROXEN EC - 375 | 375MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-05-14 | 2019-11-05 | 84067 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-NAPROXEN | 375MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258493 |